Darifenacin Hydrobromide 11 indexed presentations.
Reference only for licensed healthcare facilities. These listings support NDC-level identification and quote review, and do not imply current stock, manufacturer sponsorship, or direct purchasing status. Review NDC-level listings, compare package configurations, and request a quote review when needed.
Need a Product Not Listed? Submit a quote review for unlisted NDCs, item codes, or alternate product presentations.
Drug Search | Request a Quote Review
Generic details Review dosage forms, strengths, package variations, and manufacturer identifiers associated with Darifenacin Hydrobromide.
Indexed presentation count: 11 indexed presentations. Manufacturer identifiers Manufacturer information is shown for product identification only. Cipla USA Inc. (6) Polygen Pharmaceuticals Inc. (5) Common dosage forms: Tablet. Common presentations Compare presentation differences here, then open the table rows below for NDC-level confirmation.
Strength variation: 15 mg / 1 and 7.5 mg / 1. Package variation: 1000 Tablet, Extended Release, 30 Tablet, Extended Release, and 90 Tablet, Extended Release. Manufacturer information is shown for product identification only. Official references Use official label-search references for this generic family when your team needs supplemental labeling context.
Showing page 1 of 1 25 50 100 200
Drug Name NDC 11 Strength Dosage Form Package Quantity Darifenacin - Hydrobromide 15 mg / 1 Tablet 1000 Tablet, Extended Release 52605-0068-10 15 mg / 1 Tablet 1000 Tablet, Extended Release Darifenacin - Hydrobromide 15 mg / 1 Tablet 1000 Tablet, Extended Release 69097-0432-15 15 mg / 1 Tablet 1000 Tablet, Extended Release Darifenacin - Hydrobromide 15 mg / 1 Tablet 30 Tablet, Extended Release 52605-0068-13 15 mg / 1 Tablet 30 Tablet, Extended Release Darifenacin - Hydrobromide 15 mg / 1 Tablet 30 Tablet, Extended Release 69097-0432-02 15 mg / 1 Tablet 30 Tablet, Extended Release Darifenacin - Hydrobromide 15 mg / 1 Tablet 90 Tablet, Extended Release 52605-0068-19 15 mg / 1 Tablet 90 Tablet, Extended Release Darifenacin - Hydrobromide 15 mg / 1 Tablet 90 Tablet, Extended Release 69097-0432-05 15 mg / 1 Tablet 90 Tablet, Extended Release Darifenacin - Hydrobromide 7.5 mg / 1 Tablet 1000 Tablet, Extended Release 52605-0067-10 7.5 mg / 1 Tablet 1000 Tablet, Extended Release Darifenacin - Hydrobromide 7.5 mg / 1 Tablet 1000 Tablet, Extended Release 69097-0431-15 7.5 mg / 1 Tablet 1000 Tablet, Extended Release Darifenacin - Hydrobromide 7.5 mg / 1 Tablet 30 Tablet, Extended Release 69097-0431-02 7.5 mg / 1 Tablet 30 Tablet, Extended Release Darifenacin - Hydrobromide 7.5 mg / 1 Tablet 90 Tablet, Extended Release 52605-0067-19 7.5 mg / 1 Tablet 90 Tablet, Extended Release Darifenacin - Hydrobromide 7.5 mg / 1 Tablet 90 Tablet, Extended Release 69097-0431-05 7.5 mg / 1 Tablet 90 Tablet, Extended Release
Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.
